Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach

Abstract According to data from the last census of the Brazilian Society of Nephrology (SBN), the prevalence of hepatitis C virus (HCV) in Brazilian hemodialysis units (HU) is 3.3%, about three times higher than what is reported for the Brazilian general population. Often, professionals working in HU are faced with clinical situations that require rapid HCV diagnosis in order to avoid horizontal transmission within the units. On the other hand, thanks to the development of new antiviral drugs, the cure of patients with HCV, both in the general population and in patients with chronic kidney disease and the disease eradication, appear to be very feasible objectives to be achieved in the near future . In this scenario, SBN and the Brazilian Society of Hepatology present in this review article a proposal to approach HCV within HUs.

摘要 据巴西肾脏病学会（Brazilian Society of Nephrology, SBN）最新普查数据显示，巴西血液透析单元（hemodialysis units, HU）内的丙型肝炎病毒（hepatitis C virus, HCV）患病率为3.3%，约为巴西普通人群报告患病率的三倍。血液透析单元的从业人员常需面对需快速开展丙型肝炎病毒诊断的临床情境，以避免单元内出现水平传播。另一方面，随着新型抗病毒药物的研发进展，无论是普通人群还是慢性肾脏病患者中的丙型肝炎病毒感染者均有望实现治愈，且根除该疾病也已成为近期极具可行性的目标。在此背景下，巴西肾脏病学会（SBN）与巴西肝病学会（Brazilian Society of Hepatology）在本篇综述文章中提出了针对血液透析单元内丙型肝炎病毒感染的应对方案。